Products for Research Use Only
RegisterLogin

Upanovimab

CAT: 0804-HY-P99535-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99535-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Upanovimab (SCTA01) is a monoclonal antibody that targets the SARS-CoV-2 S protein[1].
CAS Number
2500633-46-3
Product Name Alternative
SCTA01
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/upanovimab.html
Purity
95.627
Solubility
10 mM in DMSO
Smiles
[Upanovimab]
Molecular Weight
(145.633 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]Daniele Focosi, et al. Monoclonal antibody therapies against SARS-CoV-2. Lancet Infect Dis. 2022 Nov;22 (11) :e311-e326.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3

Alternative Products

CatalogName
abx831847-01Upanovimab
GTR18334268-01Upanovimab Antibody
VK565106-01Research Grade Upanovimab
E55B0858Upanovimab (Reference antibody)
ICH5958-5mgUpanovimab Biosimilar - Research Grade
GTR18697275-01Upanovimab Chimeric Monoclonal Antibody
GTR18780849-01(Upanovimab) Biosimilar Reference Antibody
A135566Upanovimab Biosimilar (Monoclonal, IgG1, kappa)
PX-TA1798-01Upanovimab Biosimilar - Anti-Spike RBD mAb - Research Grade
RA0669-01Upanovimab (Biosimilar Reference Antibody) (SARS-CoV-2 Spike RBD)

Popular Products